Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald P Tashkin

Showing results (1-10 of 315) with videos related to

Pageof 32
Sort By:
American Journal of Respiratory and Critical Care Medicine|November 3, 2011
COPD Progression and individual rates of change in FEV1 and the BODE indexDonald P Tashkin
American Journal of Respiratory and Critical Care Medicine|July 10, 2023
Age of Initiating Smoking: An Independent Predictor of Chronic Obstructive Pulmonary Disease in Later LifeDonald P Tashkin
Expert Review of Respiratory Medicine|December 7, 2010
Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPDDonald P Tashkin
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2020
Formoterol for the Treatment of Chronic Obstructive Pulmonary DiseaseDonald P Tashkin
The Lancet. Respiratory Medicine|December 11, 2013
Future of fixed-dose longacting β2-agonist and antimuscarinic combination therapy in COPDDonald P Tashkin
Annals of the American Thoracic Society|August 7, 2024
Is Smoked Marijuana a Risk Factor for Chronic Obstructive Pulmonary Disease? An Enduring ControversyDonald P Tashkin
Seminars in Respiratory and Critical Care Medicine|August 5, 2015
Advances in Prevention and Treatment of Chronic Obstructive Pulmonary DiseaseDonald P Tashkin
Seminars in Respiratory and Critical Care Medicine|August 5, 2015
Smoking Cessation in Chronic Obstructive Pulmonary DiseaseDonald P Tashkin
The New England Journal of Medicine|September 17, 2010
Frequent exacerbations of chronic obstructive pulmonary disease--a distinct phenotype?Donald P Tashkin
The European Respiratory Journal|July 2, 2015
The respiratory health benefits of quitting cannabis useDonald P Tashkin
Pageof 32

Showing results (1-10 of 315) with videos related to

Sort By:
Pageof 32
American Journal of Respiratory and Critical Care Medicine|November 3, 2011
COPD Progression and individual rates of change in FEV1 and the BODE indexDonald P Tashkin
American Journal of Respiratory and Critical Care Medicine|July 10, 2023
Age of Initiating Smoking: An Independent Predictor of Chronic Obstructive Pulmonary Disease in Later LifeDonald P Tashkin
Expert Review of Respiratory Medicine|December 7, 2010
Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPDDonald P Tashkin
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2020
Formoterol for the Treatment of Chronic Obstructive Pulmonary DiseaseDonald P Tashkin
The Lancet. Respiratory Medicine|December 11, 2013
Future of fixed-dose longacting β2-agonist and antimuscarinic combination therapy in COPDDonald P Tashkin
Annals of the American Thoracic Society|August 7, 2024
Is Smoked Marijuana a Risk Factor for Chronic Obstructive Pulmonary Disease? An Enduring ControversyDonald P Tashkin
Seminars in Respiratory and Critical Care Medicine|August 5, 2015
Advances in Prevention and Treatment of Chronic Obstructive Pulmonary DiseaseDonald P Tashkin
Seminars in Respiratory and Critical Care Medicine|August 5, 2015
Smoking Cessation in Chronic Obstructive Pulmonary DiseaseDonald P Tashkin
The New England Journal of Medicine|September 17, 2010
Frequent exacerbations of chronic obstructive pulmonary disease--a distinct phenotype?Donald P Tashkin
The European Respiratory Journal|July 2, 2015
The respiratory health benefits of quitting cannabis useDonald P Tashkin
Pageof 32